Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country/Region, 2017, 2022 & 2028

2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Type

2.2.1 Invokana (Canagliflozin)

2.2.2 Jardiance (Empagliflozin)

2.2.3 Farxiga/Forxiga (Dapagliflozin)

2.2.4 Suglat (Ipragliflozin)

2.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type

2.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)

2.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Type (2017-2022)

2.3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Type (2017-2022)

2.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Segment by Application

2.4.1 Hospital

2.4.2 Medical Research Institute

2.4.3 Other

2.5 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application

2.5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Market Share by Application (2017-2022)

2.5.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue and Market Share by Application (2017-2022)

2.5.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Application (2017-2022)

3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Company

3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Company

3.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales by Company (2020-2022)

3.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company (2020-2022)

3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue by Company (2020-2022)

3.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2020-2022)

3.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Company (2020-2022)

3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Company

3.4 Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Location Distribution

3.4.2 Players Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Geographic Region

4.1 World Historic Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Geographic Region (2017-2022)

4.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue by Geographic Region

4.2 World Historic Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Country/Region (2017-2022)

4.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales by Country/Region (2017-2022)

4.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue by Country/Region

4.3 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth

4.4 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth

4.5 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth

4.6 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth

5 Americas

5.1 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country

5.1.1 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022)

5.1.2 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022)

5.2 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type

5.3 Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region

6.1.1 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2017-2022)

6.1.2 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2017-2022)

6.2 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type

6.3 APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country

7.1.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022)

7.1.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022)

7.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type

7.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country

8.1.1 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022)

8.1.2 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022)

8.2 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type

8.3 Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

10.3 Manufacturing Process Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

10.4 Industry Chain Structure of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors

11.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customer

12 World Forecast Review for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Geographic Region

12.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Region

12.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Region (2023-2028)

12.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Type

12.7 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Application

13 Key Players Analysis

13.1 Eli Lilly

13.1.1 Eli Lilly Company Information

13.1.2 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

13.1.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Eli Lilly Main Business Overview

13.1.5 Eli Lilly Latest Developments

13.2 Janssen Pharmaceuticals

13.2.1 Janssen Pharmaceuticals Company Information

13.2.2 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

13.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Janssen Pharmaceuticals Main Business Overview

13.2.5 Janssen Pharmaceuticals Latest Developments

13.3 Astellas

13.3.1 Astellas Company Information

13.3.2 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

13.3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Astellas Main Business Overview

13.3.5 Astellas Latest Developments

13.4 Boehringer Ingelheim

13.4.1 Boehringer Ingelheim Company Information

13.4.2 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

13.4.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Boehringer Ingelheim Main Business Overview

13.4.5 Boehringer Ingelheim Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

13.5.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 Bristol Myers Squibb

13.6.1 Bristol Myers Squibb Company Information

13.6.2 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

13.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bristol Myers Squibb Main Business Overview

13.6.5 Bristol Myers Squibb Latest Developments

13.7 Kotobuki Pharmaceutical

13.7.1 Kotobuki Pharmaceutical Company Information

13.7.2 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

13.7.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Kotobuki Pharmaceutical Main Business Overview

13.7.5 Kotobuki Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Invokana (Canagliflozin)

Table 4. Major Players of Jardiance (Empagliflozin)

Table 5. Major Players of Farxiga/Forxiga (Dapagliflozin)

Table 6. Major Players of Suglat (Ipragliflozin)

Table 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)

Table 8. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)

Table 9. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2017-2022) & ($ million)

Table 10. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2017-2022)

Table 11. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Type (2017-2022) & (USD/Kg)

Table 12. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)

Table 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)

Table 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2017-2022)

Table 15. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2017-2022)

Table 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Application (2017-2022) & (USD/Kg)

Table 17. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2020-2022) & (Kg)

Table 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company (2020-2022)

Table 19. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Company (2020-2022)

Table 21. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sale Price by Company (2020-2022) & (USD/Kg)

Table 22. Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Producing Area Distribution and Sales Area

Table 23. Players Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered

Table 24. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Geographic Region (2017-2022) & (Kg)

Table 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Geographic Region (2017-2022)

Table 29. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country/Region (2017-2022) & (Kg)

Table 32. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country/Region (2017-2022)

Table 33. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022) & (Kg)

Table 36. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2017-2022)

Table 37. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2017-2022)

Table 39. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)

Table 40. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)

Table 41. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)

Table 42. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)

Table 43. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2017-2022) & (Kg)

Table 44. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2017-2022)

Table 45. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2017-2022)

Table 47. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)

Table 48. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)

Table 49. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)

Table 50. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)

Table 51. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022) & (Kg)

Table 52. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2017-2022)

Table 53. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2017-2022)

Table 55. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)

Table 56. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)

Table 57. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)

Table 58. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2017-2022) & (Kg)

Table 60. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2017-2022) & (Kg)

Table 64. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2017-2022) & (Kg)

Table 66. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

Table 68. Key Market Challenges & Risks of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

Table 69. Key Industry Trends of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

Table 70. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List

Table 73. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customer List

Table 74. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2023-2028) & (Kg)

Table 75. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Forecast by Region

Table 76. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2023-2028) & (Kg)

Table 79. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2023-2028) & (Kg)

Table 81. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2023-2028) & (Kg)

Table 83. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2023-2028) & (Kg)

Table 85. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2023-2028) & (Kg)

Table 87. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2023-2028) & (Kg)

Table 91. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Application (2023-2028)

Table 94. Eli Lilly Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 95. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

Table 96. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 97. Eli Lilly Main Business

Table 98. Eli Lilly Latest Developments

Table 99. Janssen Pharmaceuticals Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 100. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

Table 101. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 102. Janssen Pharmaceuticals Main Business

Table 103. Janssen Pharmaceuticals Latest Developments

Table 104. Astellas Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 105. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

Table 106. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 107. Astellas Main Business

Table 108. Astellas Latest Developments

Table 109. Boehringer Ingelheim Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 110. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

Table 111. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 112. Boehringer Ingelheim Main Business

Table 113. Boehringer Ingelheim Latest Developments

Table 114. AstraZeneca Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 115. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

Table 116. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 117. AstraZeneca Main Business

Table 118. AstraZeneca Latest Developments

Table 119. Bristol Myers Squibb Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 120. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

Table 121. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 122. Bristol Myers Squibb Main Business

Table 123. Bristol Myers Squibb Latest Developments

Table 124. Kotobuki Pharmaceutical Basic Information, Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 125. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered

Table 126. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 127. Kotobuki Pharmaceutical Main Business

Table 128. Kotobuki Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

Figure 2. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2017-2028 (Kg)

Figure 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Invokana (Canagliflozin)

Figure 10. Product Picture of Jardiance (Empagliflozin)

Figure 11. Product Picture of Farxiga/Forxiga (Dapagliflozin)

Figure 12. Product Picture of Suglat (Ipragliflozin)

Figure 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2021

Figure 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2017-2022)

Figure 15. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumed in Hospital

Figure 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Hospital (2017-2022) & (Kg)

Figure 17. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumed in Medical Research Institute

Figure 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Medical Research Institute (2017-2022) & (Kg)

Figure 19. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Consumed in Other

Figure 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market: Other (2017-2022) & (Kg)

Figure 21. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2017-2022)

Figure 22. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application in 2021

Figure 23. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Company in 2021

Figure 25. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Geographic Region in 2021

Figure 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2017-2022)

Figure 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country/Region in 2021

Figure 29. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)

Figure 30. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)

Figure 31. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)

Figure 32. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)

Figure 33. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)

Figure 34. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2017-2022 (Kg)

Figure 36. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2017-2022 ($ Millions)

Figure 37. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2021

Figure 38. Americas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2021

Figure 39. United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region in 2021

Figure 44. APAC Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Regions in 2021

Figure 45. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2021

Figure 52. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2021

Figure 53. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2021

Figure 60. Egypt Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in 2021

Figure 66. Manufacturing Process Analysis of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

Figure 67. Industry Chain Structure of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles